The tuberculosis: Scientific challenges and opportunities

Public Health Reports

Volumn 113, Issue 2, 1998, Pages 128-136

  Ginsberg, Ann M ^a,b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b MSC 7630 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; BACTERIUM ANTIBODY; BCG VACCINE; DNA VACCINE; TUBERCULOSTATIC AGENT; BACTERIAL VACCINE;

DELAYED HYPERSENSITIVITY; EPIDEMIC; HUMAN; INCIDENCE; MORTALITY; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; SPUTUM CULTURE; TUBERCULOSIS; ANIMAL; ARTICLE; FINANCIAL MANAGEMENT; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MYCOBACTERIUM; RESEARCH; TIME; TUBERCULIN TEST; UNITED STATES;

ANIMALS; ANTIBODIES, BACTERIAL; ANTITUBERCULAR AGENTS; BACTERIAL VACCINES; BCG VACCINE; DNA, BACTERIAL; HUMANS; INCIDENCE; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; RESEARCH; RESEARCH SUPPORT; TIME FACTORS; TUBERCULIN TEST; TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT; UNITED STATES; VACCINES, DNA;

EID: 0032013882     PISSN: 00333549     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. Reichman LB. Tuberculosis elimination - what's to stop us? Int J Tuberc Lung Dis 1997;1:3-11.
2. Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons - Florida and New York, 1988-1991. MMWR Morb Mortal Wkly Rep 1991;40:585-91.
3. Centers for Disease Control and Prevention (US). Reported tuberculosis in the United States, 1996. Atlanta: Public Health Service; 1997 Jul.
4. Moore M, Onorato I, McCray E, Castro K. Trends in drug-resistant tuberculosis in the United States, 1993-1996. JAMA 1997;278:833-7.
5. Raviglione M, Dye C, Schmidt S, Kochi A. Assessment of worldwide tuberculosis control. Lancet 1997;350:624-9.
6. World Health Organization. WHO report on the tuberculosis 3 epidemic 1997. Geneva: WHO; 1997.
7. China Tuberculosis Control Collaboration. Results of directly observed short-course chemotherapy in 112,842 Chinese patients with smear-positive tuberculosis. Lancet 1996;347:358-62.
8. Laal S, Samanich KM, Sonnenberg MG, Belisle JT, O'Leary J, Simberkoff MS, Zolla-Pazner S. Surrogate marker of preclinical tuberculosis in HIV infection: antibodies to an 88kDa secreted antigen of Mycobocterium tuberculosis. J Infect Dis 1997;176:133-43.
9. Silver RF, Wallis RS, Ellner JJ. Mapping of T cell epitopes of the 30-kDa alpha antigen of Mycobocterium bovis strain bacillus Calmette-Guerin in purified protein derivative (PPD)-positive individuals. J Immunol 1995;154:4665-74.
10. Carriere C, Riska P, Zhimony O, Kriakov S, Bardarov S, Burns J, et al. Conditionally-replicating luciferase reporter phages: improved sensitivity for rapid diagnosis and assessment of drug susceptibility of Mycobacterium tuberculosis. J Clin Microbiol 1997;35:3232-9.
11. Casper C, Singh SP, Rave S, Daley CL, Schecter GS, Riley LW, Kreiswirth BN, Small PM. The transcontinental transmission of tuberculosis: a molecular epidemiological assessment. Am J Public Health 1996;86:551-3.
12. Bifani PJ, Plikaytis BB, Kapur V, Stockbauer K, Pan X, Lutfey ML, et al. Origin and interstate spread of a New York City multidrug-resistant Mycobocterium tuberculosis clone family. JAMA 1996;275:452-7.
13. Bradford WZ, Martin JN, Reingold AL, Schecter GF, Hopewell PC, Small PM. The changing epidemiology of acquired drug-resistant tuberculosis in San Francisco, USA. Lancet 1996;348:928-31.
14. Dessen A, Quemard A, Blanchard JS, Jacobs WR Jr, Sacchettini JC. Crystal structure and function of the isoniazid target of Mycobocterium tuberculosis. Science 1995;267:1638-41.
15. Belisle JT, Vissa VD, Sievert T, Takayama K, Brennan PJ, Besra GS. Role of the major antigen of Mycobocterium tuberculosis in cell wall biogenesis. Science 1997;276:1420-2.
16. Yuan Y, Crane DC Musser JM, Sreevatsan S, Barry CE 3rd. MMAS-I, the branch point between cis- and trans-cyclopropane-containing oxygenated mycolates in Mycobocterium tuberculosis. J Biol Chem 1997; 272:10041-9.
17. Harth G, Lee B, Horwitz MA. High level heterologous expression and secretion in rapidly growing nonpathogenic mycobacteria of four major Mycobocterium tuberculosis extracellular proteins considered to be leading vaccine candidates and drug targets. Infect Immun 1997;65:2321-8.
18. Collins L, Franzblau SG. Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobocterium tuberculosis and Mycobocterium avium. Antimicrob Agents Chemother 1997;41:1004-9.
19. Kelly BP, Furney SK, Jessen MT, Orme IM. Low-dose aerosol infection model for testing drugs for efficacy against Mycobocterium tuberculosis. Antimicrob Agents Chemother 1996;40:2809-12.
20. Arain TM, Resconi AE, Singh DC, Stover CK. Reporter gene technology to assess activity of antimycobacterial agents in macrophages. Antimicrob Agents Chemother 1996;40:1542-4.
21. World Health Organization and United Nations Children's Fund. State of the world's vaccines and immunization. Geneva: WHO; 1996.
22. Rodrigues LC, Diwan VK, Wheeler JG. Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis. Int J Epidemiol 1993;22:1154-8.
23. Comstock GW. Field trials of tuberculosis vaccines: how could we have done them better? Control Clin Trials 1994;15:247-76.
24. Colditz GA, Brewer TF, Berkey CS, Wilson WE, Burdick E, Fineburg HV, Mosteller R. Efficacy of BCG vaccine in the prevention of tuberculosis, meta-analysis of the published literature. JAMA 1994;271:698-702.
25. Behr MA, Small PM. Has BCG attenuated to impotence? Nature 1997; 389:133-4.
26. Fine PEM. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 1995;346:1339-45.
27. Karonga Prevention Trial Group. Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobocterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Lancet 1996;348:17-24.
28. Murray PJ, Aldovini A, Young RA. Manipulation and potentiation of antimycobacterial immunity using recombinant bacille Calmette-Guerin strains that secrete cytokines. Proc Natl Acad Sci U S A 1996;93:934-9.
29. O'Donnell MA, Aldovini A, Duba RB, Yang H, Seilvasi A, Young RA, DeWolf WC. Recombinant Mycobocterium bovis BCG secreting functional interleukin-2 enhances gamma interferon production by splenocytes. Infect Immun 1994;62:2508-14.
30. Ginsburg-Jacobs GT, Johnson JL, Boom WH, Wallis RS, Whalen CC, Ginsberg AM. TB vaccines: how close to human testing? report of a workshop. Tuberc Lung Dis. In press 1997.
31. McAdam RA, Weisbrod TR, Martin J, Scuderi JD, Brown AM, Cirillo JD, et al. In vivo growth characteristics of leucine and methionine auxotrophic mutants of Mycobocterium tuberculosis BCG generated by transposon mutagenesis. Infect Immun 1995:63:1004-12.
32. Bange FC, Brown AM, Jacobs WR. Leucine auxotrophy restricts growth of Mycobocterium bovis BCG in macrophages. Infect Immun 1996: 64:1794-9.
33. Guleria I, Teitelbaum R, McAdam RA, Kaplana G, Jacobs WR Jr, Bloom BR. Auxotrophic vaccines for tuberculosis. Nat Med 1996;2:334-7.
34. Valway S, Sanchez M, Shinnick T, Orme I, Agerton T, Onorato I. Extensive transmission of Mycobocterium tuberculosis due to increased virulence. Presented at 35th Annual Meeting of ISDA: 1997 Sep 13-16; San Francisco, CA.
35. Bardarov S, Kriakov J, Carriere C, Yu S, Vaamonde C, McAdam RA, et al. Conditionally replicating mycobacteriophages: a system for transposon delivery to Mycobocterium tuberculosis. Proc Natl Acad Sci U S A 1997;94:10961-6.
36. Pelicic V, Jackson M, Reyrat J-M, Jacobs WR Jr, Gicquel B, Guilhot C. Efficient allelic exchange and transposon mutagenesis in Mycobocterium tuberculosis. PNAS 1997;94:10955-60.
37. Mahairas CG, Sabo PJ, Hickey MJ, Singh DC, Stover CK. Molecular analysis of genetic differences between Mycobocterium bows BCG and virulent M. bovis. J Bacteriol 1996:178:1274-82.
38. Orme I. Progress in the development of new vaccines against tuberculosis. Int J Tuberc Lung Dis 1997;1:95-100.
39. Jesdale BM, Deocampo G, Meisell J, Beall J, Marinello MJ, Chicz RM, De Groot AS. Matrix-based prediction of MHC binding peptides: the EpiMatrix algorith, reagent for HIV research. Proceedings of Vaccines '97: Molecular Approaches to the Control of Infectious Diseases; 1996 Sep 9-13; Cold Spring Harbor, NY. Plainview (NY): Cold Spring Harbor Laboratory Press; 1997.
40. Beckman EM, Porcelli SA, Morita CT, Behar SM, Furlong ST, Brenner MB. Recognition of a lipid antigen by CDI-restricted alpha beta+ T cells. Nature 1994; 372:691-4.
41. Robbins JB, Schneerson R, Anderson P, Smith DH. The 1996 Albert Lasker Medical Research Awards. Prevention of systemic infections, especially meningitis, caused by Hoemopnilus influenzae type b: impact on public health and implications for other polysaccharide-based vaccines. JAMA 1996;276:1181-5.
42. Donnelly JJ, Ulmer JB, Lui MA. Immunization with DNA. J Immunol Methods 1994;176:145-52.
43. Silva SL, Lowrie DB. A single mycobacterial protein (hsp60) expressed by a transgenic antigen-presenting cell vaccinates mice against tuberculosis. Immunology 1994;82:244-8.
44. Huygen K, Content J, Denis O, Montgomery DL, Yawman AM, Deck RR, et al. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat Med 1996;2:893-8.
45. Tascon RE, Colston MJ, Ragno S, Stavropoulos E, Gregory D, Lowrie DB. Vaccination against TB by DNA injection. Nat Med 1996;2:888-92.
46. Barry MA, Lai WC, Johnston SA. Protection against Mycoplasma infection using expression library immunization. Nature 1995;377:632-5.
47. Gupta HP, Singh NB, Mathur IS, Gupta SK. Mycobocterium habana, a new immunogenic strain in experimental tuberculosis of mice. Indian J Exp Biol 1979;17:1190-3.
48. Collins DM, Kawakami RP, de Lisle GW, Pascopella L, Bloom BR, Jacobs WR Jr. Mutation of the principal sigma factor causes loss of virulence in a strain of the Mycobocterium tuberculosis complex. Proc Natl Acad Sci U S A 1995;92:8036-40.
49. Stanford JL, Rook GA, Bahr GM, Dowlati Y, Ganapati R, Ghazi Saidi K, et al. Mycobacterium vaccae in immunoprophylaxis and immunotherapy of leprosy and tuberculosis. Vaccine 1990;8:525-30.
50. Fodor SP, Rava RP, Huang XC, Pease AC, Holmes CP, Adams CL. Multiplexed biochemical assays with biological. Nature 1993;364:555-6.
51. Velculescu VE, Zhang L, Vogelstein B, Kinzler KW. Serial analysis of gene expression. Science 1995;270:484-7.
52. Schena M, Shalon D, Davis RW, Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995:270:467-70.